Sanmina Corp. Hits New 52-Week High at USD 193.30

Sanmina Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 193.30 on April 24, 2026. This achievement underscores the company's impressive performance over the past year, with a remarkable increase of 189.66%, significantly outpacing the S&P 500's growth of 30.64% during the same period. The company's market capitalization stands at USD 12,249 million, reflecting its position within the small-cap segment. Sanmina Corp. maintains a price-to-earnings (P/E) ratio of 39.00, indicating investor expectations for future growth. Additionally, the company has a debt-to-equity ratio of 0.31, suggesting a relatively low level of debt compared to equity, which can be a positive indicator of financial stability. With a return on equity of 12.64% and a price-to-book ratio of 4.95, Sanmina Corp. continues to demonstrate solid financial metrics that contribute to its current market standing. The stock's previous 52-week low was recorded at USD 74.90, highlighting the significant upward trajectory it has experienced.